Annalisa Paviglianiti: Real-World Outcomes of Maribavir for CMV After Hematopoietic Cell Transplantation
Annalisa Paviglianiti, Hematologist at Hospital de la Santa Creu i Sant Pau, shared a post on LinkedIn about a recent article she and her colleges co-authored, published in The Lancet Infectious Diseases, adding:
“Excited to share that our article on maribavir is now published online!
This European cohort is the first to report such a large number of patients treated with MBV for CMV infection in the HCT setting.
Encouraging response rates, along with a favorable safety profile.
Promising outcomes, even beyond current EMA-approved indications.
Curious to hear how others are using MBV in practice?”
Title: Maribavir for clinically significant cytomegalovirus infection in haematopoietic cell transplant recipients in Europe: a real-world multicentre retrospective registry study
Authors: Annalisa Paviglianiti, Per Ljungman, Rafael de la Camara, Gloria Tridello, Juana Schwartz, Nina Knelange, Arancha Bermudez Rodriguez, María Suárez-Lledó, Johan Maertens, Maria Stamouli, Francis Ayuk, Candela Ceballos, Maria Huguet, Felipe Peña Muñoz, Pablo Granados, Alienor Xhaard, Jurgen Kuball, Chiara Nozzoli, Jan Styczynski, Dina Averbuch, Francesca Kinsella, Alejandro Avendano, Hakan Ozodogu, Jose Rifon Roca, Nicole Morrow, Marta Stanzani, Marina Popova, Jerome Cornillon, Tsila Zuckerman, Massimo Martino, Johannes Clausen

Stay updated on all scientific advances with Hemostasis Today.
-
Oct 23, 2026, 17:45Lucy Brook: Had the Privilege of Attending the Blood 2026 Conference with New Zealand Blood Service
-
Oct 23, 2026, 16:05Platelet Secretion Defects and Their Role in the Diagnosis of Bleeding Disorders
-
Oct 23, 2026, 16:00Hemophilia Alliance team in New Orleans at the ATHN Data Summit
-
Oct 23, 2026, 15:49Brian Sapp: Why Exact Calf Vein Naming Is Critical for DVT Diagnosis?
-
Oct 23, 2026, 15:33Smitirupa Mishra: A Systematic Approach to Bone Marrow Examination
-
Oct 23, 2026, 15:29José Antonio García Erce: Preoperative Anemia Emerges as a Modifiable Surgical Risk in New POWER Study
-
Oct 23, 2026, 15:13Reza Shojaei: Manufactured Red Blood Cells vs Blood Donation
-
Oct 23, 2026, 14:29Jean Jacques Kiladjian: International Scientific Exchange at IHCAMS in Tianjin
-
Oct 23, 2026, 14:11Aravind Palraj: The Prolonged aPTT Puzzle in SLE